New Yorker Infected With EEE Dies; Vt. Mosquito Testing Shows Improvement
September 24, 2024
Morning Briefing
New York Gov. Kathy Hochul, a Democrat, on Monday announced ways the state will try to curb the disease’s spread, including making mosquito repellent available to visitors at state parks and campgrounds.
HIV Infection Rate Tumbled By 20% In San Francisco Last Year
September 24, 2024
Morning Briefing
The number of new diagnoses in 2023 was 133, the lowest it has been in decades. The abrupt drop in infections represents a success after years of slow progress against the disease. Also in the news: A study shows diabetes drug metformin might slow aging.
Amneal Pharmaceuticals Sues To Block Colorado’s Free EpiPen Push
September 24, 2024
Morning Briefing
Colorado’s law, passed last year, to make Amneal provide free generic EpiPens to pharmacies is facing a challenge from the company, which argues it’s effectively an illegal property taking. Among other news, Purdue Pharma’s settlement talks with the Sackler family are extended to November.
Jurors Reject Mental Illness Argument For Colorado Supermarket Gunman
September 24, 2024
Morning Briefing
Lawyers for the gunman, who fatally shot 10 people in a Boulder grocery store in 2021, tried to argue his mental illness made him incapable of knowing right from wrong. Jurors disagreed. Other news includes a battle over a DuPont trust, the drug-related death of a trans activist, and more.
Morning Briefing for Tuesday, September 24, 2024
September 24, 2024
Morning Briefing
KFF Health News is on Instagram and TikTok ! Watch our videos and follow along as we break down health care headlines and policy.
US Severe Obesity Rate Swells
September 24, 2024
Morning Briefing
About 1 in 10 of survey respondents indicated they are severely obese. It’s too soon to know whether obesity treatments and drugs will ease the problem, researchers say. Meanwhile, Novo Nordisk’s CEO is expected to testify today in a Senate panel hearing about the high cost of weight loss drugs.
First Edition: Tuesday, Sept. 24, 2024
September 24, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations.
Aumentan los casos de hipertensión mortal durante el embarazo
By Katheryn Houghton
September 24, 2024
KFF Health News Original
Hoy en día, más embarazadas reciben diagnósticos de presión arterial peligrosamente alta, un hallazgo que podría salvar vidas.
Vance Rewrites History About Trump and Obamacare
By Julie Appleby
September 24, 2024
KFF Health News Original
During the Trump administration, enrollment in Affordable Care Act health plans fell by more than 2 million people and the number of uninsured Americans rose.
Estudio revela que los casos de gripe aviar siguen sin detectarse
By Amy Maxmen
September 23, 2024
KFF Health News Original
Si los casos de gripe aviar no se van informando, los oficiales de salud corren el riesgo de tardar en notar si el virus se vuelve más contagioso.
The Public Health Consequences of Public Housing Failures
By Renuka Rayasam
September 23, 2024
KFF Health News Original
Every year more than 10,000 taxpayer-supported public housing units are lost to disrepair. But federal lawmakers routinely ignore the full amount, around $115 billion, needed to keep the units in “decent, safe and sanitary” condition. One-time funds for public housing repairs were cut from the final version of the 2022 Inflation Reduction Act to appeal […]
Viewpoints: How Easily Could Obamacare Be Dismantled?; More Menopause Research Is Crucial
September 23, 2024
Morning Briefing
Editorial writers weigh in on these public health issues.
Appeals Court Revives PhRMA Lawsuit Against Medicare Drug Negotiations
September 23, 2024
Morning Briefing
Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three largest pharmacy benefit managers of inflating insulin prices.
Congress Agrees On Stopgap Funding Bill, Likely Averting Federal Shutdown
September 23, 2024
Morning Briefing
The plan does not include any part of the SAVE Act, which would have required proof of citizenship to register to vote. House Speaker Mike Johnson and former president Donald Trump had pushed hard for its inclusion. Also: SNAP benefits and the PACT Act.
Tennessee Law Barring Adults From Helping Girls Get Abortions Is Delayed
September 23, 2024
Morning Briefing
The law, which is being challenged in court, makes it a crime for any adult who “intentionally recruits, harbors, or transports” a pregnant child without parental consent. Meanwhile, Texas sees a 56% increase in maternal deaths from 2019 to 2022.
Civil Rights Groups Sound Alarm Over Trump’s Agenda Targeting Gender Care
September 23, 2024
Morning Briefing
The former president’s position on LGBTQ+ issues has shifted over the years, but his second-term agenda is said to target gender care providers, worrying civil rights groups. Meanwhile, Stat reports an anti-pharma campaign bus is touring in swing states, though its funding remains unknown.
White House Touts Progress In Its Efforts To Stem Gun Violence
September 23, 2024
Morning Briefing
After the Bipartisan Safer Communities Act became law in 2022, more than 8,000 gun sales to youth and domestic abusers have been blocked after background checks. The White House also says homicides are down 17% and mass shootings this year are down 20%.
FDA Approves At-Home Nasal Spray Flu Vaccine, Will Be Available Next Year
September 23, 2024
Morning Briefing
The FluMist vaccine will be able to be ordered from an online pharmacy, but it will still require a prescription. Meanwhile, U.S. covid levels decline, while whooping cough cases surge.
Many Lawsuits Over Femur Risks Of Merck Drug Fosamax Can Now Proceed
September 23, 2024
Morning Briefing
More than 500 lawsuits, which a U.S. appeals court revived on Friday, allege Merck & Co. failed to warn patients that its osteoporosis drug Fosamax raised the risk of thigh bone fractures. Separately, a J&J subsidiary has filed for bankruptcy for the third time as part of its tactic to tackle thousands of lawsuits alleging its talc products caused cancer.
